PARP1/2 drugs for Ovarian Cancer
2 tracked PARP1/2 drugs in the Ovarian Cancer race. The class explanation lives on the PARP1/2 page; the full indication pipeline across every mechanism is on the Ovarian Cancer page.
1 approved / phase 41 Phase 2
Head-to-head evidence: Niraparib vs stenoparib